Defanging a Killer Virus
Defanging a Killer Virus
Professor Christopher Basler has spent his career stalking Ebola, and recently he hit upon a surprising discovery that could suggest new ways to treat the deadly infection.
Biomedical Sciences Researcher Gets Two NIH Grants Totaling $816,534 to Study Coronaviruses
Biomedical Sciences Researcher Gets Two NIH Grants Totaling $816,534 to Study Coronaviruses
Professor Christopher Basler has received two grants from the National Institutes of Health to study two coronaviruses that cause human disease: Middle East respiratory syndrome (MERS) coronavirus and SARS-CoV-2.
Host Proteins That Impair Ebola Virus Infection Identified by Biomedical Sciences Researchers
Host Proteins That Impair Ebola Virus Infection Identified by Biomedical Sciences Researchers
Scientists in the Institute for Biomedical Sciences have shed light on how cells can slow replication of the Ebola virus, preventing infection. “We hope these findings will enable us to develop new ways to prevent or treat Ebola.”
Compounds That Inhibit SARS-CoV-2 Replication Identified by Biomedical Sciences Researchers
Compounds That Inhibit SARS-CoV-2 Replication Identified by Biomedical Sciences Researchers
Compounds targeting two key enzymes are potent inhibitors of SARS-CoV-2, the virus that causes COVID-19, according to a study led by the Institute for Biomedical Sciences at Georgia State.
Global Study Identifies Common Vulnerabilities Across SARS-CoV-2, SARS-CoV-1 and MERS Coronaviruses
Global Study Identifies Common Vulnerabilities Across SARS-CoV-2, SARS-CoV-1 and MERS Coronaviruses
There are common vulnerabilities among three lethal coronaviruses, SARS-CoV-2, SARS-CoV-1 and MERS-CoV, such as frequently hijacked cellular pathways, that could lead to promising targets for broad coronavirus inhibition, according to a study by an international research team that includes scientists from the Institute for Biomedical Sciences at Georgia State University.
Biomedical Sciences Researcher Gets COVID-19 Grant To Study Enzymes Critical for SARS-CoV-2 Replication
Biomedical Sciences Researcher Gets COVID-19 Grant To Study Enzymes Critical for SARS-CoV-2 Replication
Christopher Basler, professor and director of the Center for Microbial Pathogenesis in the Institute for Biomedical Sciences at Georgia State University, has received a $100,000 COVID-19 Fast Grant to study enzymes that are critical for the replication of SARS-CoV-2, the virus that causes COVID-19.
Biomedical Sciences Researcher Gets $2.94 Million Federal Grant To Study Unique Features of Ebola and Marburg Viruses
Biomedical Sciences Researcher Gets $2.94 Million Federal Grant To Study Unique Features of Ebola and Marburg Viruses
Dr. Christopher Basler, professor and director of the Center for Microbial Pathogenesis in the Institute for Biomedical Sciences at Georgia State University, has received a five-year, $2.94 million federal grant to study unique features of Ebola and Marburg viruses that control how the virus family expresses its genes and escapes immune responses.
Understanding The Enemy
Understanding The Enemy
A professor and director of the Center for Microbial Pathogenesis at Georgia State, Chris Basler is studying how the novel coronavirus interacts with the cell it infects.
Biomedical Sciences Researchers Provide Methods to Inactivate and Safely Study SARS-CoV-2
Biomedical Sciences Researchers Provide Methods to Inactivate and Safely Study SARS-CoV-2
Detailed methods on how to perform research on SARS-CoV-2, the virus that causes COVID-19, including procedures that effectively inactivate the virus to enable safe study of infected cells have been identified by virologists in the Institute for Biomedical Sciences at Georgia State University.
Georgia State Biomedical Scientists Join the Global Race to Fight COVID-19
Georgia State Biomedical Scientists Join the Global Race to Fight COVID-19
A multidisciplinary team of researchers in the Institute for Biomedical Sciences is combining their expertise to develop therapeutics and vaccines to fight COVID-19.